Literature DB >> 11157869

Cytokine production in a murine model of recurrent herpetic stromal keratitis.

T H Stumpf1, C Shimeld, D L Easty, T J Hill.   

Abstract

PURPOSE: To determine the pattern of cytokine production in the cornea and its relationship with viral antigens, in our murine model of recurrent ocular herpes simplex virus (HSV)-1 infection.
METHODS: Six weeks after corneal inoculation with HSV-1, the eyes of latently infected and control mice were UV irradiated and examined for signs of disease and viral reactivation. The eyes of five mice with recurrent stromal disease and two controls were processed for immunohistochemistry on days 4, 7, 10, and 14 after irradiation. Sections were double stained for viral antigens and one of the following cytokines: interleukin (IL)-1ss, IL-2, IL-4, IL-6, IL-10, IL-12, and interferon (IFN)-gamma.
RESULTS: Fifty percent of mice showed signs of recurrent stromal disease, the severity of which peaked on day 10 after UV irradiation. There was a large cellular infiltrate in the stroma of all the corneas with recurrent disease and the predominant cytokines were IL-1ss, IL-6, IL-10, IL-12, and IFN-gamma, all present in large numbers of cells on the days studied. There were very few cells producing IL-2 and IL-4. Control eyes had no significant cytokine-producing cells in the stroma.
CONCLUSIONS: These observations suggest that recurrent herpetic stromal keratitis (HSK) may not be characterized by a classic T-helper (Th)1 or Th2 response. However, the large number of IFN-gamma(+) and IL-12(+) cells and the relative absence of IL-4 favors a Th1 response, and despite the numerous IL-10(+) cells, the overall balance of cytokine production appears to be proinflammatory.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157869

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  25 in total

1.  Corneal stromal cells selectively inhibit production of anti-inflammatory cytokines by activated T cells.

Authors:  V Holán; A Vítová; J Pindjáková; M Krulová; A Zajícová; M Filipec
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

2.  IL-6 Contributes to Corneal Nerve Degeneration after Herpes Simplex Virus Type I Infection.

Authors:  Ana J Chucair-Elliott; Jeremy Jinkins; Meghan M Carr; Daniel J J Carr
Journal:  Am J Pathol       Date:  2016-08-03       Impact factor: 4.307

3.  CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis.

Authors:  Devin M West; Chelsea R Del Rosso; Xiao-Tang Yin; Patrick M Stuart
Journal:  J Immunol       Date:  2014-01-17       Impact factor: 5.422

4.  A novel p40-independent function of IL-12p35 is required for progression and maintenance of herpes stromal keratitis.

Authors:  Gregory M Frank; Sherrie J Divito; Dawn M Maker; Min Xu; Robert L Hendricks
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-05       Impact factor: 4.799

5.  Activated inflammatory infiltrate in HSV-1-infected corneas without herpes stromal keratitis.

Authors:  Sherrie J Divito; Robert L Hendricks
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

6.  Involvement of p63 in the herpes simplex virus-1-induced demise of corneal cells.

Authors:  László Orosz; Eva Gallyas; Lajos Kemény; Yvette Mándi; Andrea Facskó; Klára Megyeri
Journal:  J Biomed Sci       Date:  2010-06-07       Impact factor: 8.410

7.  Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1.

Authors:  Partha S Bhattacharjee; Donna M Neumann; Timothy P Foster; Saadallah Bouhanik; Christian Clement; Dass Vinay; Hilary W Thompson; James M Hill
Journal:  Exp Eye Res       Date:  2008-05-18       Impact factor: 3.467

8.  Topical antisense-oligonucleotides targeting IFN-gamma mRNA improve incidence and severity of herpetic stromal keratitis by cytokine specific and sequence unspecific effects.

Authors:  Susanne Wasmuth; Dirk Bauer; Klaus-Peter Steuhl; Arnd Heiligenhaus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-11-21       Impact factor: 3.117

9.  Protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice.

Authors:  C M Richards; R Case; T R Hirst; T J Hill; N A Williams
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Lornoxicam suppresses recurrent herpetic stromal keratitis through down-regulation of nuclear factor-kappaB: an experimental study in mice.

Authors:  Jie Yin; Zhenping Huang; Yuan Xia; Fei Ma; Li Jing Zhang; Heng Hui Ma; Li Li Wang
Journal:  Mol Vis       Date:  2009-06-14       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.